| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/08/2012 | EP2413936A1 Co-crystal of etravirine and nicotinamide |
| 02/08/2012 | EP2413935A1 Low dose pipamperone in treating mood disorders |
| 02/08/2012 | EP2413934A1 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response |
| 02/08/2012 | EP2413933A2 Composition of 2,4,6-trifluoro-n-ý6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl¨-benzamide |
| 02/08/2012 | EP2413932A1 Inhibitors of akt activity |
| 02/08/2012 | EP2413931A1 Solid pharmaceutical composition comprising amlodipine and losartan and process for producing same |
| 02/08/2012 | EP2413930A1 Oral formulations of diphenylsulfonamide endothelin and angiotensin ii receptor agonists to treat elevated blood pressure and diabetic nephropathy |
| 02/08/2012 | EP2413929A2 Method of treating cognitive impairment |
| 02/08/2012 | EP2413928A1 Use of flavonoids to increase the bioavailability of hesperetin |
| 02/08/2012 | EP2413927A1 Anti-biofilm carbonate compounds for use in oral care compositions |
| 02/08/2012 | EP2413926A2 Compositions of cholinesterase inhibitors |
| 02/08/2012 | EP2413925A1 Satiety-inducing composition |
| 02/08/2012 | EP2413924A1 L-ornithine phenyl acetate and methods of making thereof |
| 02/08/2012 | EP2413923A1 Dietary supplement comprising alpha keto acids for supporting diabetes therapy |
| 02/08/2012 | EP2413922A1 Antibacterial composition comprising 4 -isopropyl-3-methylpheno and zinc ions |
| 02/08/2012 | EP2413921A1 4 -isopropyl-3-methylphenol for the treatment of inflammation |
| 02/08/2012 | EP2413920A1 Curcuminoids in combination docetaxel for the treatment of cancer and tumour metastasis |
| 02/08/2012 | EP2413919A1 Nicotine dissolving film with or without menthol |
| 02/08/2012 | EP2413918A1 Solid lipid nanoparticles encapsulating minoxidil, and aqueous suspension containing same |
| 02/08/2012 | EP2413917A2 Drug delivery system and methods of use |
| 02/08/2012 | EP2413916A2 Lyophilization cakes of proteasome inhibitors |
| 02/08/2012 | EP2413913A2 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same |
| 02/08/2012 | EP2413912A1 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof |
| 02/08/2012 | EP2413910A1 Pills comprising dapoxetin and dry processing methods for the production thereof |
| 02/08/2012 | EP2413908A1 Pharmaceutical composition containing a limus family immunosuppressive macrolide |
| 02/08/2012 | EP2413902A1 Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| 02/08/2012 | EP2413899A1 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration |
| 02/08/2012 | EP2413898A1 Modified-release pharmaceutical drug composition |
| 02/08/2012 | EP2413876A1 A multidose package, course and method of treatment for delivering predetermined multiple doses of a pharmaceutical |
| 02/08/2012 | EP2413718A1 Reduction of risk of obesity |
| 02/08/2012 | EP2413710A1 Ready-to-use, stable suspension of partially amorphous carotenoid particles |
| 02/08/2012 | EP2413701A1 Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
| 02/08/2012 | EP2413698A1 Method of treating osteoporosis |
| 02/08/2012 | EP2413696A1 Compositions for treatment of alzheimer's disease |
| 02/08/2012 | EP2413693A1 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof |
| 02/08/2012 | EP2321321B1 Triazolo [4, 5-d]pyramidine derivatives and their use as purine receptor antagonists |
| 02/08/2012 | EP2234611B1 Composition for treating sterile inflammation |
| 02/08/2012 | EP2176251B1 5-pyridinone substituted indazoles and pharmaceutical compositions thereof |
| 02/08/2012 | EP2166852B1 Therapeutic pyrazoloquinoline derivatives |
| 02/08/2012 | EP2148874B1 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| 02/08/2012 | EP2129661B1 Quinoline derivatives as crth2 receptor ligands |
| 02/08/2012 | EP2124977B1 Method for treating or preventing systemic inflammation |
| 02/08/2012 | EP2124554B1 Compositions and methods for the treatment of cancer |
| 02/08/2012 | EP2121653B1 Carboxamide compounds and their use as calpain inhibitors |
| 02/08/2012 | EP2102235B1 Treatment of cachexia |
| 02/08/2012 | EP2098515B1 Substituted carbinol compound |
| 02/08/2012 | EP2086968B1 5-hydroxymethyl-oxazolidin-2-one derivatives |
| 02/08/2012 | EP2077995B1 Methods of synthesizing pharmaceutical salts of a factor xa inhibitor |
| 02/08/2012 | EP2035432B1 2-(Substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
| 02/08/2012 | EP1989208B1 New morphine compounds for pharmaceutical compositions |
| 02/08/2012 | EP1966195B1 5-aryl isoxazolines for controlling invertebrate pests |
| 02/08/2012 | EP1933809B1 Compositions for nasal delivery |
| 02/08/2012 | EP1755577B1 Novel use of peptide compounds for treating amyotrophic lateral sclerosis |
| 02/08/2012 | EP1706403B1 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
| 02/08/2012 | EP1648948B1 Thermosensitive polymers for therapeutic use and methods of preparation |
| 02/08/2012 | EP1633365B1 Macrocyclic quinazoline derivatives as antiproliferative agents |
| 02/08/2012 | EP1567117B1 Prevention and treatment of microbe-mediated epithelial disorders |
| 02/08/2012 | EP1545557B1 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 02/08/2012 | EP1509518B1 Calcium receptor modulating agents |
| 02/08/2012 | EP1429786B1 D-mannose contraceptives |
| 02/08/2012 | CN1934091B 治疗神经变性障碍的咪唑化合物 Treatment of neurodegenerative disorders imidazole compound |
| 02/08/2012 | CN1652757B Edg受体结合剂在癌症中的应用 Edg receptor binding agents in cancer of the |
| 02/08/2012 | CN1620413B 还原型辅酶Q<sub>10</sub>的稳定方法和组合物 Coenzyme Q <sub> 10 </ sub> stabilization methods and compositions |
| 02/08/2012 | CN102348796A Novel cancer antigen eEF2 |
| 02/08/2012 | CN102348714A Steroid compound |
| 02/08/2012 | CN102348713A CARBA-nucleoside analogs for antiviral treatment |
| 02/08/2012 | CN102348712A Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections |
| 02/08/2012 | CN102348708A Prodrug forms of kinase inhibitors and their use in therapy |
| 02/08/2012 | CN102348707A Pyrimidinecarboxamide derivatives as inhibitors of SYK kinase |
| 02/08/2012 | CN102348703A Compounds for the treatment of metabolic disorders |
| 02/08/2012 | CN102348702A Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
| 02/08/2012 | CN102348698A Inhibitors of beta-secretase |
| 02/08/2012 | CN102348692A Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators |
| 02/08/2012 | CN102348691A Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenyiethoxy) hexyl]amino}-l- hydroxyethyl)-8-hydroxyquinolin-2(1h)-one. |
| 02/08/2012 | CN102348690A Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides) |
| 02/08/2012 | CN102348689A Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors |
| 02/08/2012 | CN102348686A Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 02/08/2012 | CN102348685A Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer |
| 02/08/2012 | CN102348683A Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient |
| 02/08/2012 | CN102348682A 1,1,1-trifluoro-2-hydroxypropyl compounds |
| 02/08/2012 | CN102348678A Novel eicosanoid derivatives |
| 02/08/2012 | CN102348668A Compounds and uses thereof for treating inflammation and modulating immune responses |
| 02/08/2012 | CN102348482A Process for preparation of hexadecyl cis-9-tetradecenoate and hexadecyl cis-10-tetradecenoate |
| 02/08/2012 | CN102348469A Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| 02/08/2012 | CN102348458A Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
| 02/08/2012 | CN102348457A Compositions and methods for prophylaxis and treatment of addictions |
| 02/08/2012 | CN102348456A Use of deferiprone for treatment and prevention of iron-related eye disorders |
| 02/08/2012 | CN102348454A Oil-based preparation containing antiprotozoal triazines and anthelmintic cyclodepsipeptides |
| 02/08/2012 | CN102344633A Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| 02/08/2012 | CN102344500A Prepared polygonum multiflorum polysaccharide and application thereof in preparing anti-aging medicament |
| 02/08/2012 | CN102344482A Betulinol derivant, preparation method and usage |
| 02/08/2012 | CN102344481A Derivatives of 3-O-caffeoyloleanane type pentacyclic triterpene, preparation method thereof and application thereof |
| 02/08/2012 | CN102344476A Thymidine cyclophosphate compound and antitumor application thereof |
| 02/08/2012 | CN102344475A Scutellarin derivative and preparation method and application thereof |
| 02/08/2012 | CN102344458A Cefprozil compound crystal and medicinal composition thereof |
| 02/08/2012 | CN102344457A Spirocyclic aminoquinolones as gsk-3 inhibitors |
| 02/08/2012 | CN102344455A Daphnane diterpene orthoester compound, medicinal composition thereof and preparation method and application thereof |
| 02/08/2012 | CN102344454A Wikstroemia indica (L.) C.A.Mey extract as well as preparation method and application thereof |
| 02/08/2012 | CN102344447A Moxifloxacin hydrochloride monohydrate crystal form and preparation method thereof |
| 02/08/2012 | CN102344445A Optical voidness quinazoline compound |